Massimo Collino Selected Research

Massimo Collino Research Topics

Disease

27	Inflammation (Inflammations) 01/2022 - 02/2008
21	Ischemia 01/2021 - 08/2005
19	Reperfusion Injury 02/2021 - 01/2006
16	Sepsis (Septicemia) 01/2022 - 02/2008
12	Hemorrhagic Shock 07/2022 - 09/2011
11	Insulin Resistance 01/2021 - 10/2009
10	Obesity 01/2021 - 06/2011
9	Multiple Organ Failure (MODS) 07/2022 - 06/2015
8	Wounds and Injuries (Trauma) 07/2022 - 05/2013
8	Body Weight (Weight, Body) 01/2021 - 07/2013
8	Infarction (Infarctions) 01/2020 - 09/2008
6	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018 - 03/2009
5	Hemorrhage 07/2022 - 06/2012
5	Stroke (Strokes) 12/2021 - 01/2006
5	Pneumonia (Pneumonitis) 01/2018 - 12/2010
5	Necrosis 11/2013 - 02/2006
5	Endotoxemia 07/2013 - 11/2004
4	Shock 01/2022 - 11/2004
4	Type 2 Diabetes Mellitus (MODY) 01/2020 - 01/2018
4	Myocardial Infarction 01/2018 - 08/2010
3	Cardiomyopathies (Cardiomyopathy) 01/2022 - 11/2016
3	Neoplasms (Cancer) 01/2022 - 01/2019
3	Non-alcoholic Fatty Liver Disease 01/2021 - 10/2009
3	Proteinuria 01/2021 - 01/2020
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 12/2011
3	Lung Injury 01/2018 - 11/2004
3	Metabolic Diseases (Metabolic Disease) 01/2018 - 01/2013
3	Dyslipidemias (Dyslipidemia) 09/2014 - 06/2011
2	Hypotension (Low Blood Pressure) 01/2022 - 12/2021
2	Fatty Liver 01/2021 - 01/2019
2	Acute Kidney Injury (Acute Renal Failure) 07/2017 - 05/2012
2	Septic Shock (Toxic Shock Syndrome) 05/2016 - 12/2010
2	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2016 - 08/2012
2	Hypoxia (Hypoxemia) 01/2016 - 08/2012
2	Anemia 07/2015 - 09/2011
2	Heart Failure 11/2013 - 07/2013
2	Critical Illness (Critically Ill) 03/2013 - 09/2011

Drug/Important Bio-Agent (IBA)

15	InflammasomesIBA 01/2022 - 01/2013
9	FructoseIBA 01/2021 - 10/2009
9	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2013 - 06/2008
8	Proteins (Proteins, Gene)FDA Link 12/2021 - 02/2008
7	CytokinesIBA 01/2022 - 08/2010
7	Phosphotransferases (Kinase)IBA 01/2021 - 07/2013
6	Advanced Glycation End ProductsIBA 01/2022 - 05/2016
6	Peroxidase (Myeloperoxidase)IBA 01/2022 - 11/2004
6	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 10/2016
6	LipidsIBA 01/2021 - 08/2010
6	SugarsIBA 01/2020 - 06/2011
6	Erythropoietin FDA Link 09/2013 - 09/2011
5	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2022 - 02/2008
5	Pharmaceutical PreparationsIBA 01/2022 - 10/2016
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2021 - 02/2006
5	NF-kappa B (NF-kB)IBA 12/2021 - 01/2006
5	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2021 - 02/2008
5	Insulin (Novolin)FDA Link 01/2021 - 01/2009
5	LipopolysaccharidesIBA 01/2015 - 08/2005
5	Glycogen Synthase (Synthase I)IBA 06/2012 - 09/2008
5	PPAR gammaIBA 08/2010 - 08/2005
4	Agammaglobulinaemia Tyrosine KinaseIBA 12/2021 - 01/2019
4	CreatinineIBA 07/2017 - 11/2004
4	AntioxidantsIBA 01/2017 - 08/2006
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2008 - 01/2006
3	EndotoxinsIBA 01/2022 - 08/2005
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022 - 08/2006
3	Interleukin-6 (Interleukin 6)IBA 12/2021 - 02/2008
3	acalabrutinibIBA 12/2021 - 01/2019
3	salicylhydroxamic acid (SHAM)IBA 11/2020 - 03/2013
3	ibrutinibIBA 10/2020 - 01/2019
3	CholesterolIBA 01/2020 - 08/2010
3	Analgesics (Analgesic Drugs)IBA 01/2020 - 01/2019
3	cibinetideIBA 02/2018 - 09/2011
3	Alanine Transaminase (SGPT)IBA 01/2018 - 11/2004
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2018 - 12/2010
3	Protein Isoforms (Isoforms)IBA 01/2018 - 06/2008
3	NucleotidesIBA 10/2016 - 01/2016
3	(4- (((2- (3- fluoro- 4- (trifluoromethyl)phenyl)- 4- methyl- 1,3- thiazol- 5- yl)methyl)sulfanyl)- 2- methylphenoxy)acetic acidIBA 01/2013 - 08/2010
3	LigandsIBA 05/2012 - 02/2008
3	Staphylococcal Protein A (Protein A)IBA 01/2009 - 08/2006
2	baricitinibIBA 07/2022 - 01/2020
2	Janus KinasesIBA 07/2022 - 01/2020
2	Janus Kinase InhibitorsIBA 07/2022 - 01/2020
2	Interleukin-10 (Interleukin 10)IBA 01/2022 - 11/2013
2	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2021 - 01/2016
2	Annexin A1IBA 01/2019 - 01/2018
2	Mitogen-Activated Protein KinasesIBA 01/2018 - 01/2006
2	Peptides (Polypeptides)IBA 01/2018 - 09/2011
2	Streptozocin (Streptozotocin)FDA Link 01/2018 - 01/2011
2	ArtesunateIBA 01/2018 - 01/2017
2	LinagliptinIBA 01/2018 - 01/2018
2	Transcription Factors (Transcription Factor)IBA 07/2017 - 12/2010
2	SodiumIBA 10/2016 - 03/2009
2	NLR ProteinsIBA 03/2016 - 01/2016
2	InterleukinsIBA 11/2013 - 03/2013
2	RelaxinIBA 11/2013 - 01/2013
2	BilirubinIBA 07/2013 - 11/2004

Therapy/Procedure

10	Resuscitation 07/2022 - 06/2012
9	Ligation 01/2022 - 12/2010
8	Punctures 01/2022 - 12/2010
7	Therapeutics 01/2022 - 11/2004
2	Nephrectomy 07/2017 - 01/2017